4 Midcap Stocks Priced Between Rs 1,000 and 2,000 to Watch for Future Multibagger Potential: Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs

Stocks priced between Rs 1,000 and 2,000 to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs meet that test, with market caps from Rs 32,408 crore to Rs 90,385 crore and Coforge offering the strongest latest-quarter profit growth at 49.19%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a share price between Rs 1,000 and Rs 2,000, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a share price between Rs 1,000 and Rs 2,000, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening stocks priced between Rs 1,000 and 2,000 usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 27 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Stocks Priced Between Rs 1,000 and 2,000 and Why Do They Attract Multibagger Interest?

Stocks priced between Rs 1,000 and 2,000 are shares that trade between Rs 1,000 and Rs 2,000 apiece, a popular price range where many established and fast growing mid sized companies sit. The four here cover IT services, auto components, hospitals and diagnostics.

A mid range share price is easy for retail investors to buy in lots, and when it comes with rising profit it points to a business that keeps building value. Within stocks priced between Rs 1,000 and 2,000, the four companies show rising profit. For stocks priced between Rs 1,000 and 2,000, both FY26 and the latest quarter showed growth. Whichever way you read stocks priced between Rs 1,000 and 2,000, the common thread is rising profit backed by complete financial data. Investors researching stocks priced between Rs 1,000 and 2,000 get a fuller picture by reading growth and valuation together. The table below lines up stocks priced between Rs 1,000 and 2,000 on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use stocks priced between Rs 1,000 and 2,000 as a starting point for your own research.

Stocks Priced Between Rs 1,000 and 2,000 at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 27 October 2026. Narayana Health has the lowest PE of the group at 42.44, while Dr Lal PathLabs posts the highest return on equity at 20.13%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Coforge	1,997	90,385	47.07	17.66	16.31%	0.08	1,008.10 to 2,021.20
Uno Minda	1,085	65,032	50.38	37.22	17.53%	0.40	994.00 to 1,355.00
Narayana Hrudayalaya	1,713.20	34,664	42.44	60.75	17.76%	1.29	1,589.00 to 2,093.30
Dr Lal PathLabs	1,901.80	32,408	59.32	60.75	20.13%	0.08	1,272.60 to 2,038.60

Coforge: 23.72% Profit CAGR Since FY22

Coforge is an IT services company serving clients in travel, banking, insurance and other industries. It reported FY26 revenue of Rs 16,475.90 crore, up 34.63% year on year, and net profit of Rs 1,674.50 crore, up 73.79%. Net profit has compounded at 23.72% a year since FY22, while revenue has grown 26.26% a year. Operating margin was 17.40% in FY26. The debt-to-equity ratio is 0.08, which keeps interest costs low.

In the June 2026 quarter, revenue rose 49.19% to Rs 5,554.50 crore and net profit grew 49.19% to Rs 531.70 crore. The share price has gained 73.24% over five years and 10.25% over the past year. The stock trades at a PE of 47.07 against an industry PE of 17.66, with a return on equity of 16.31%.

Uno Minda: 38.65% Profit CAGR Since FY22

Uno Minda makes switches, lighting, sensors and safety components for two-wheeler, passenger and commercial vehicle makers. It reported FY26 revenue of Rs 19,692.02 crore, up 17.19% year on year, and net profit of Rs 1,284.06 crore, up 25.82%. Net profit has compounded at 38.65% a year since FY22, while revenue has grown 23.83% a year. Operating margin was 12.75% in FY26. The debt-to-equity ratio is 0.40.

The stock trades at a PE of 50.38 against an industry PE of 37.22, with a return on equity of 17.53%. In the June 2026 quarter, revenue rose 23.60% to Rs 5,563.16 crore and net profit grew 2.10% to Rs 315.51 crore. The share price has gained 187.71% over five years. Domestic institutions raised their holding from 15.85% in June 2025 to 17.53% in June 2026.

Narayana Health: 24.06% Profit CAGR Since FY22

Narayana Health runs a network of multi-speciality hospitals, with a strong cardiac care franchise and a presence in India and the Cayman Islands. It reported FY26 revenue of Rs 7,996.25 crore, up 43.43% year on year, and net profit of Rs 810.46 crore, up 2.61%. Net profit has compounded at 24.06% a year since FY22, while revenue has grown 20.95% a year. Operating margin was 21.25% in FY26.

In the June 2026 quarter, revenue rose 77.60% to Rs 2,719.11 crore and net profit grew 5.37% to Rs 207.27 crore. The share price has gained 225.59% over five years. Domestic institutions raised their holding from 7.76% in September 2025 to 10.68% in September 2026. The stock trades at a PE of 42.44 against an industry PE of 60.75, below the sector average, with a return on equity of 17.76%.

Dr Lal PathLabs: Return on Equity of 20.13%

Dr Lal PathLabs is one of India’s leading diagnostic chains, running laboratories and collection centres across the country. It reported FY26 revenue of Rs 2,864.18 crore, up 12.11% year on year, and net profit of Rs 509.75 crore, up 3.56%. Net profit has compounded at 9.83% a year since FY22, while revenue has grown 7.56% a year. Operating margin was 30.90% in FY26. The debt-to-equity ratio is 0.08, which keeps interest costs low.

The stock trades at a PE of 59.32 against an industry PE of 60.75, below the sector average, with a return on equity of 20.13%. In the June 2026 quarter, revenue rose 18.87% to Rs 829.60 crore and net profit grew 27.24% to Rs 170.50 crore. The share price is up 19.11% over the past year. Domestic institutions raised their holding from 17.91% in June 2025 to 21.59% in June 2026.

Stocks Priced Between Rs 1,000 and 2,000: Financial Comparison on Growth and Margins

The table compares scale and growth across these stocks priced between Rs 1,000 and 2,000. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	4-Year Net Profit CAGR	Operating Margin (Latest Quarter)
Coforge	16,475.90	1,674.50	34.63%	26.26%	23.72%	18.63%
Uno Minda	19,692.02	1,284.06	17.19%	23.83%	38.65%	11.26%
Narayana Health	7,996.25	810.46	43.43%	20.95%	24.06%	18.75%
Dr Lal PathLabs	2,864.18	509.75	12.11%	7.56%	9.83%	35.03%

Check the Univest Screener for live data on these stocks priced between Rs 1,000 and 2,000

Institutional Holding in Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs

Institutional holding shows who is backing these stocks priced between Rs 1,000 and 2,000 alongside the promoter. The table uses the latest reported quarter for each. Coforge has the deepest institutional backing, with FII and DII together holding 66.93% as of June 2026. Domestic institutions increased their holding over the past year in Uno Minda (from 15.85% to 17.53%), Narayana Health (from 7.76% to 10.68%) and Dr Lal PathLabs (from 17.91% to 21.59%).

Stock	Promoter	FII	DII	Public	Quarter
Coforge	Nil	24.31%	42.62%	33.07%	June 2026
Uno Minda	68.36%	8.15%	17.53%	5.96%	June 2026
Narayana Health	63.27%	9.01%	10.68%	17.04%	September 2026
Dr Lal PathLabs	53.19%	17.36%	21.59%	7.86%	June 2026

Risks to Weigh in Stocks Priced Between Rs 1,000 and 2,000

Being careful with stocks priced between Rs 1,000 and 2,000 means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Coforge trades at a PE of 47.07 against an industry PE of 17.66, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Stocks Priced Between Rs 1,000 and 2,000

Picking from stocks priced between Rs 1,000 and 2,000 comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (17.66 to 60.75) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs live prices.

Conclusion

Among stocks priced between Rs 1,000 and 2,000, Coforge stands out for the strongest latest-quarter profit growth at 49.19%, Uno Minda for the fastest profit growth, 38.65% a year since FY22, Narayana Health for the biggest five-year price gain at 225.59% and Dr Lal PathLabs for the highest return on equity at 20.13%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks priced between Rs 1,000 and 2,000 should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Stocks Priced Between Rs 1,000 and 2,000 to Watch

Which are the best stocks priced between Rs 1,000 and 2,000 to watch for multibagger potential?

Ans. Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs are the 4 names this list highlights, with market caps of Rs 90,385 crore, Rs 65,032 crore, Rs 34,664 crore and Rs 32,408 crore respectively. Coforge is notable for the strongest latest-quarter profit growth at 49.19%. Uno Minda stands out for the fastest profit growth, 38.65% a year since FY22. Narayana Health offers the biggest five-year price gain at 225.59%. Dr Lal PathLabs brings the highest return on equity at 20.13%. These are watchlist names for stocks priced between Rs 1,000 and 2,000, not recommendations, so match each one to your own risk profile and time horizon.

Is Dr Lal PathLabs a good stock for long-term investors?

Ans. Dr Lal PathLabs has a return on equity of 20.13%, a PE of 59.32 against an industry PE of 60.75 and a market cap of Rs 32,408 crore. Net profit has compounded at 9.83% a year since FY22, and FY26 revenue rose 12.11% while June 2026 quarter net profit grew 27.24%. Long-term returns in stocks priced between Rs 1,000 and 2,000 depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Uno Minda become a multibagger from here?

Ans. Uno Minda has already gained 187.71% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks priced between Rs 1,000 and 2,000 requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.65% a year since FY22, and FY26 revenue rose 17.19%. At a PE of 50.38 against an industry PE of 37.22, valuation should be checked against that growth before investing.

What is the market cap of Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs?

Ans. As of 27 October 2026, Coforge has a market cap of Rs 90,385 crore, Uno Minda has a market cap of Rs 65,032 crore, Narayana Health has a market cap of Rs 34,664 crore and Dr Lal PathLabs has a market cap of Rs 32,408 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks priced between Rs 1,000 and 2,000.

What are the risks of investing in stocks priced between Rs 1,000 and 2,000?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Coforge trades at a PE of 47.07 against an industry PE of 17.66, so earnings growth needs to hold up.

Why is Coforge trading at a PE of 47.07?

Ans. Coforge’s PE of 47.07 compares with an industry PE of 17.66. The market is paying a premium for a return on equity of 16.31%, profit growth of 23.72% a year since FY22 and latest-quarter profit growth of 49.19%, which also means the stock is more sensitive if growth slows. Investors in stocks priced between Rs 1,000 and 2,000 who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Coforge, Uno Minda, Narayana Health and Dr Lal PathLabs?

Ans. As of the latest reported quarter, FII and DII together hold 66.93% of Coforge (24.31% and 42.62%), 25.68% of Uno Minda (8.15% and 17.53%), 19.69% of Narayana Health (9.01% and 10.68%) and 38.95% of Dr Lal PathLabs (17.36% and 21.59%). Rising institutional holding is a useful signal in stocks priced between Rs 1,000 and 2,000, though it should be read with earnings trends rather than on its own.